Literature DB >> 14531216

Endocytosis and signal transduction: basic science update.

Jiang Liu1, Joseph I Shapiro.   

Abstract

Endocytosis can be separated into the categories of phagocytosis and pinocytosis. Phagocytosis can be distinguished from pinocytosis primarily by the size of particle ingested and by its dependence on actin polymerization as a key step in particle ingestion. Several specific forms of pinocytosis have been identified that can be distinguished based on their dependence on clathrin or caveolin. Both clathrin- and caveolin-dependent pinocytosis appear to require the participation of dynamin to internalize the plasma membrane. Other, less well-characterized forms of pinocytosis have also been described. Although endocytosis has long been known to affect receptor density, recent studies have demonstrated that endocytosis through clathrin- and caveolin-dependent processes plays a key role in receptor-mediated signal transduction. In some cases, blockade of these processes attenuates, or even prevents, signal transduction from taking place. This information, coupled with a better understanding of endocytosis mechanisms, will help advance the field of cell biology as well as present new targets for drug development and disease treatment.

Mesh:

Substances:

Year:  2003        PMID: 14531216     DOI: 10.1177/1099800403256860

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  17 in total

1.  Salinity-dependent diatom biosilicification implies an important role of external ionic strength.

Authors:  Engel G Vrieling; Qianyao Sun; Mingwen Tian; Patricia J Kooyman; Winfried W C Gieskes; Rutger A van Santen; Nico A J M Sommerdijk
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

Review 2.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors:  Andrew M Shen; Tamara Minko
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

3.  Lapatinib-incorporated lipoprotein-like nanoparticles: preparation and a proposed breast cancer-targeting mechanism.

Authors:  Li Zhang; Shuang Zhang; Shao-Bo Ruan; Qian-Yu Zhang; Qin He; Hui-le Gao
Journal:  Acta Pharmacol Sin       Date:  2014-06       Impact factor: 6.150

4.  Identification of tubby and tubby-like protein 1 as eat-me signals by phage display.

Authors:  Nora B Caberoy; Dony Maiguel; Youngbae Kim; Wei Li
Journal:  Exp Cell Res       Date:  2009-10-22       Impact factor: 3.905

5.  Can phage display be used as a tool to functionally identify endogenous eat-me signals in phagocytosis?

Authors:  Nora B Caberoy; Yixiong Zhou; Wei Li
Journal:  J Biomol Screen       Date:  2009-06-16

6.  PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.

Authors:  Saijie Zhu; Minghuang Hong; Lihong Zhang; Guotao Tang; Yanyan Jiang; Yuanying Pei
Journal:  Pharm Res       Date:  2009-10-28       Impact factor: 4.200

7.  Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages.

Authors:  Asha Jayakumar; Robyn Widenmaier; Xiaojing Ma; Mary Ann McDowell
Journal:  J Parasitol       Date:  2008-02       Impact factor: 1.276

8.  A genome-wide RNAi screen identifies MASK as a positive regulator of cytokine receptor stability.

Authors:  Katherine H Fisher; Maria Fragiadaki; Dhamayanthi Pugazhendhi; Nina Bausek; Maria A Arredondo; Sally J Thomas; Stephen Brown; Martin P Zeidler
Journal:  J Cell Sci       Date:  2018-07-06       Impact factor: 5.285

9.  Enhanced clathrin-dependent endocytosis in the absence of calnexin.

Authors:  Hao-Dong Li; Wen-Xin Liu; Marek Michalak
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

10.  Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization.

Authors:  Huile Gao; Zhi Yang; Shuang Zhang; Shijie Cao; Shun Shen; Zhiqing Pang; Xinguo Jiang
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.